Joincare Pharmaceutical Group Industry Co Ltd (600380) - Total Liabilities
Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has total liabilities worth CN¥10.95 Billion CNY (≈ $1.60 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Joincare Pharmaceutical Group Industry C to track the company's year-over-year net asset growth rate.
Joincare Pharmaceutical Group Industry Co Ltd - Total Liabilities Trend (1997–2025)
This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 600380 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seadrill Limited
NYSE:SDRL
|
USA | $1.09 Billion |
|
Air France-KLM SA
PA:AF
|
France | €41.04 Billion |
|
Vapores
SN:VAPORES
|
Chile | CL$62.81 Million |
|
Beijing Haohua Energy Resource Co Ltd
SHG:601101
|
China | CN¥13.97 Billion |
|
Worthington Industries Inc
NYSE:WOR
|
USA | $790.31 Million |
|
CREDITACCESS GRAMEEN LIMITED
NSE:CREDITACC
|
India | Rs211.54 Billion |
|
Ratch Group Public Company Limited
BK:RATCH
|
Thailand | ฿130.36 Billion |
|
Brookfield Wealth Solutions Ltd.
NYSE:BNT
|
USA | $135.91 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Joincare Pharmaceutical Group Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Joincare Pharmaceutical Group Industry C (600380) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Joincare Pharmaceutical Group Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
The table below shows the annual total liabilities of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥11.05 Billion ≈ $1.62 Billion |
-10.33% |
| 2024-12-31 | CN¥12.32 Billion ≈ $1.80 Billion |
-10.21% |
| 2023-12-31 | CN¥13.72 Billion ≈ $2.01 Billion |
+0.07% |
| 2022-12-31 | CN¥13.71 Billion ≈ $2.01 Billion |
+25.49% |
| 2021-12-31 | CN¥10.92 Billion ≈ $1.60 Billion |
+22.47% |
| 2020-12-31 | CN¥8.92 Billion ≈ $1.31 Billion |
+10.76% |
| 2019-12-31 | CN¥8.05 Billion ≈ $1.18 Billion |
-7.31% |
| 2018-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
+1.11% |
| 2017-12-31 | CN¥8.59 Billion ≈ $1.26 Billion |
+27.56% |
| 2016-12-31 | CN¥6.74 Billion ≈ $985.83 Million |
+3.83% |
| 2015-12-31 | CN¥6.49 Billion ≈ $949.47 Million |
+17.06% |
| 2014-12-31 | CN¥5.54 Billion ≈ $811.09 Million |
+17.41% |
| 2013-12-31 | CN¥4.72 Billion ≈ $690.83 Million |
+13.39% |
| 2012-12-31 | CN¥4.16 Billion ≈ $609.24 Million |
+24.11% |
| 2011-12-31 | CN¥3.35 Billion ≈ $490.87 Million |
+87.33% |
| 2010-12-31 | CN¥1.79 Billion ≈ $262.03 Million |
+2.67% |
| 2009-12-31 | CN¥1.74 Billion ≈ $255.23 Million |
-10.99% |
| 2008-12-31 | CN¥1.96 Billion ≈ $286.75 Million |
+0.81% |
| 2007-12-31 | CN¥1.94 Billion ≈ $284.46 Million |
+4.31% |
| 2006-12-31 | CN¥1.86 Billion ≈ $272.71 Million |
+36.66% |
| 2005-12-31 | CN¥1.36 Billion ≈ $199.56 Million |
-5.37% |
| 2004-12-31 | CN¥1.44 Billion ≈ $210.88 Million |
+4.17% |
| 2003-12-31 | CN¥1.38 Billion ≈ $202.44 Million |
+170.51% |
| 2002-12-31 | CN¥511.40 Million ≈ $74.83 Million |
+47.72% |
| 2001-12-31 | CN¥346.20 Million ≈ $50.66 Million |
-31.01% |
| 2000-12-31 | CN¥501.77 Million ≈ $73.43 Million |
+1.96% |
| 1999-12-31 | CN¥492.14 Million ≈ $72.02 Million |
+8.74% |
| 1998-12-31 | CN¥452.60 Million ≈ $66.23 Million |
+33.54% |
| 1997-12-31 | CN¥338.94 Million ≈ $49.60 Million |
-- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more